Use of an antioxidant for treating and/or preventing surface...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/44 (2006.01) A61K 31/385 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2449825

The invention concerns a pharmaceutical composition for treating surface ocular disorders. The invention is characterised in that an antioxidant selected from the group consisting of superoxide dismutases, analogues and derivatives of said superoxide dismutases, racemic alpha-lipoic acid and its enantiomers R+, R-, as well as mixtures of said compounds, is used for making a medicine designed for treating and/or preventing surface ocular disorders. The invention is applicable in human and veterinary medicine.

L'invention concerne une composition pharmaceutique pour le traitement des affections oculaires de surface. Selon l'invention, un antioxydant sélectionné dans le groupe constitué par les SODs, les mimétiques et dérivés de ces SODs, l'acide alpha-lipoïque racémique et ses énantiomères R?+¿, R?-¿ ainsi que les mélanges de ces composés, est utilisé pour la fabrication d'un médicament destiné au traitement et/ou à la prévention des affections oculaires de surface. L'invention trouve application en médecine humaine et vétérinaire.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of an antioxidant for treating and/or preventing surface... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of an antioxidant for treating and/or preventing surface..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of an antioxidant for treating and/or preventing surface... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1381492

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.